Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome
Ayşegül Oruç+8 more
openalex +1 more source
Complement in Antibody-Mediated Rejection of the Kidney Graft: From Pathophysiology to Clinical Practice. [PDF]
Sorohan BM+7 more
europepmc +1 more source
Advances in Research on the Release of von Willebrand Factor from Endothelial Cells through the Membrane Attack Complex C5b-9 in Sepsis. [PDF]
Liu Y+9 more
europepmc +1 more source
Advances in the treatment of neuromyelitis optic spectrum disorder. [PDF]
Yang X, Zhang S, Feng J, Qin X.
europepmc +1 more source
Marked clinical and jitter improvement after eculizumab in refractory myasthenia
Vern C. Juel+7 more
openalex +2 more sources
The Silent Culprit: Paroxysmal Nocturnal Hemoglobinuria Masquerading as Cryptogenic Stroke. [PDF]
Sidhu AS+3 more
europepmc +1 more source
Differential effects of C5 inhibition, C3 inhibition, and alternative pathway inhibition on bacterial killing in vitro. [PDF]
Ter Avest M+6 more
europepmc +1 more source
Complement factor H antibody-associated atypical hemolytic uremic syndrome and eculizumab treatment
Zeynep Yürük Yıldırım+5 more
openalex +2 more sources
Macrophage activation syndrome successfully treated with eculizumab and emapalumab: a case report. [PDF]
Faggioli P+10 more
europepmc +1 more source
Atypical presentation of H1N1-induced thrombotic microangiopathy with CD46 gene mutation . [PDF]
Pal A+8 more
europepmc +1 more source